Clorox/$CLX
1D1W1MYTD1Y5YMAX
Capital at risk
About Clorox
Since its inception more than 100 years ago, Clorox has expanded to operate in an array of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Nearly 85% of Clorox's sales come from its home turf.
- Ticker
- $CLX
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 9,200
- Headquarters
- Oakland, United States
- Website
- www.thecloroxcompany.com
Clorox Metrics
BasicAdvanced
$10B
17.42
$4.81
0.54
$4.97
5.97%
Price and volume
Market cap
$10B
Beta
0.54
52-week high
$128.90
52-week low
$81.60
Average daily volume
3.1M
Dividend rate
$4.97
Financial strength
Current ratio
0.658
Quick ratio
0.337
Long term debt to equity
17.496
Total debt to equity
21.905
Dividend payout ratio (TTM)
102.56%
Interest coverage (TTM)
7.53%
Profitability
EBITDA (TTM)
1,140
Gross margin (TTM)
42.78%
Net profit margin (TTM)
8.74%
Operating margin (TTM)
13.23%
Effective tax rate (TTM)
24.02%
Revenue per employee (TTM)
$730,000
Management effectiveness
Return on assets (TTM)
9.16%
Return on equity (TTM)
163.76%
Valuation
Price to earnings (TTM)
17.422
Price to revenue (TTM)
1.519
Price to book
112.6
Price to tangible book (TTM)
-2.95
Price to free cash flow (TTM)
25.197
Free cash flow yield (TTM)
3.97%
Free cash flow per share (TTM)
3.326
Dividend yield (TTM)
5.93%
Forward dividend yield
5.97%
Growth
Revenue change (TTM)
-5.41%
Earnings per share change (TTM)
-26.23%
3-year revenue growth (CAGR)
-3.11%
10-year revenue growth (CAGR)
1.55%
3-year earnings per share growth (CAGR)
58.85%
10-year earnings per share growth (CAGR)
-0.23%
3-year dividend per share growth (CAGR)
1.59%
10-year dividend per share growth (CAGR)
4.80%
What the Analysts think about Clorox
Analyst ratings (Buy, Hold, Sell) for Clorox stock.
Analyst projections of the future price of Clorox stock.
Bulls say / Bears say
GOJO gives Clorox a larger health-and-hygiene platform, with the business now representing more than half of sales. Management expects FY27 sales to rise 13%–14%, with GOJO contributing about 9.5 percentage points, and says the acquisition should be accretive to adjusted earnings as revenue synergies build. (The Clorox Company, The Motley Fool)
The US ERP rollout is complete, removing a major execution burden and creating a platform for better supply-chain planning, trade-spend control and productivity. Clorox says its roughly $580 million transformation investment should generate efficiencies over time, with optimisation benefits expected to build from FY27 onwards. (SEC, Stock Analysis)
Brand momentum is improving in important businesses. Home Care delivered eight straight quarters of market-share growth, while Glad and Hidden Valley recovered share; Clorox also reported that its new Clorox PURE product was selling faster than expected and that innovation investment had nearly doubled as a share of sales. (The Motley Fool, The Clorox Company)
The headline FY27 growth outlook is helped heavily by easy comparisons rather than a strong underlying rebound. Organic sales are forecast to grow 3.5%–4.5%, but more than 3.5 percentage points come from lapping the prior year's ERP-related inventory drawdown, after FY26 organic sales fell 8%. (The Clorox Company, SEC)
Profitability remains under pressure even after the ERP disruption. Clorox expects FY27 gross margin of about 42% while facing more than $200 million of inflation, and says the full-year margin will not fully recover; Q4 FY26 gross margin had already fallen to 41.3%. (The Clorox Company, The Motley Fool)
The turnaround still depends on winning back volume from value-seeking shoppers without damaging brand economics. Management says pricing will be targeted and that positive pricing with negative volume is built into the outlook, while litter and some other categories still need operational and marketing investment to regain competitiveness. (The Motley Fool, The Clorox Company)
Data summarised monthly by Lightyear AI. Last updated on 27 Sept 2026.
Clorox Financial Performance
Revenues and expenses
Clorox Earnings Performance
Company profitability
Upcoming events
Clorox News
AllArticlesVideos
Funds containing Clorox
AllEURGBPUSD
Fund name | Fund size | $CLX weighting |
|---|---|---|
VanEck Morningstar Wide Moat€GMVM | €407M | 2.07% |
VanEck Morningstar Wide Moat£MOGB | £354M | 2.07% |
SPDR S&P US Dividend Aristocrats€SPYD | €3.3B | 0.44% |
SPDR S&P US Dividend Aristocrats£USDV | £2.8B | 0.44% |
iShares S&P 500 Consumer Staples Sector€2B7D | €450M | 0.34% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.